课题基金 / 基金详情

AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ

AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ
金刚烷胺用于预防成人精神病首发患者体重增加
批准号:
7377533
负责人:
KAREN A GRAHAM
金额:
$0.25万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

KAREN A GRAHAM的其他基金

相似基金

相关文献

中文摘要
翻译
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。这项研究的目的是确定一种叫做金刚烷胺的药物是否可以防止服用奥氮平时体重增加。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research is to determine if a medication called amantadine can prevent weight gain while taking olanzapine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE
AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ
AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ
INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE
海外基金